These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
An initial public offering (IPO) has a special allure: It draws in speculative investors eager to see stocks soar in the initial days of trading. In weak markets, only the strongest candidates pull off an IPO. Lesser-quality companies delay or withdraw the offering, typically citing market conditions.
Since the beginning of March, these three biotechs successfully raised money and began trading. Let's take a look at them now.
Image Source: Getty Images.
Source Fool.com
